| Submission declined on 20 May 2024 by Qcne (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 3 April 2024 by Chaotic Enby (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by Chaotic Enby 7 months ago. | |
Comment: Still too much companyspeak like "targeting opportunities" or "underlining its commitment". You should refrain from making subjective statements in general, and limit yourself to relevant facts that have been stated in secondary sources. Chaotıċ Enby (talk · contribs) 23:36, 3 April 2024 (UTC)
 | |
| Company type | Private |
|---|---|
| Industry | Private Equity |
| Founded | 2006 |
| Headquarters | Warsaw, Poland |
| Products | Private equity funds, buyouts |
| AUM | €1.3 billion (2024)[1] |
| Website | abris-capital |
Abris Capital Partners is an independent private equity and investment advisory firm investing in Central and Eastern Europe (CEE). The firm has approximately €1.3 billion of assets under management and operates from offices in Warsaw, Poland, and Bucharest, Romania.[2] Abris has been a certified B Corporation (certification) since 2023.[3]
History
editAbris was founded in 2006 to invest in the fast-growing mid-market segment once addressed by Advent International. George Swirski, previously a partner at Advent, joined forces with Neil Milne, the founder of Copernicus Capital Partners, a CEE focused private equity affiliate of Advent, to raise €320 million for its first institutional fund. This closed in 2007 with the Harvard University endowment as the cornerstone investor.
The second Abris fund was raised in 2012 with investment commitments totalling €450m. The ownership of the firm was widened to include Pawel Gierynski, who became Managing Partner in 2018, and Steve Richmond, now the CFO. In 2017, Abris raised a third fund with investment commitments totalling €502 million.[4]
Abris’ investors include a wide range of institutional investors from Europe, the United States, Australia and the Middle East. These include corporate and public pension plans, Financial institutions, Fund of funds and university endowments.
Strategy
editAbris invests in mid-market companies within CEE, aiming to help entrepreneurs and management teams expanding within the region and internationally. The firm invests in five strategic areas: Health care, Circular economy, specialty Manufacturing, Logistics and Technology.
Abris was certified as a B Corp in May 2023, becoming the first private equity firm in Central Europe to achieve this accreditation.[5]
Notable investments
editNotable Abris investments include:
- Masterlease: buyout of a vehicle leasing business from GMAC; exit via an Initial public offering on the Warsaw Stock Exchange.[6]
- Alumetal: MBO and expansion of an aluminium processing business; exit via an IPO on the Warsaw Stock Exchange.[7]
- VelvetCARE: Creation of Poland’s largest branded tissue manufacturer which, under Abris' ownership, increased sales by over 250% and EBITDA by over 500%; the business was sold to Partners Group in 2023.[8]
- ScanMed: Buy-and-build acquisition strategy to create a large Polish medical group.[9][10]
Awards
editAbris has received awards recognising its commitment to improving portfolio ESG standards:
- In 2021, Abris received UN Principles for Responsible Investment’s Emerging Markets ‘Initiative of the Year Award’ for its ‘Agile & Comprehensive ESG management system’ project[11][12]
- In 2021, the Polish Private Equity and Venture Capital Association (PSIK) named Abris’ 'ESG Universe 2023' as its ‘ESG Initiative of the Year’[13]
- In 2022, Abris was named the Winner in the 'Best ESG Investment Fund: Private Equity' category at the ESG Investing Awards.[14]
- In 2024, Abris was named the Winner in the 'ESG Champion of the Year - Mid-Cap' category at the Private Equity Awards.[15]
References
edit- ^ Cite error: The named reference
wsj-maxarwas invoked but never defined (see the help page). - ^ "Abris Capital Partners, Who We Are".
- ^ "Abris attains B Corporation Status". New Private Markets. 15 May 2023.
- ^ "Abris Capital Partners, Who We Are".
- ^ "Abris-CEE Holdings Limited". B Corporation.
- ^ "Prime Car Drops on Warsaw Trading Debut After $69 Million IPO". Bloomberg. 16 April 2014.
- ^ "Alumetal Declines in Warsaw Debut After $96 Million IPO". Bloomberg. 17 July 2014.
- ^ "Partners Group to acquire Velvet CARE, one of the leading European manufacturers of hygiene paper products". Business Insider. 11 December 2023.
- ^ "Abris mulls sale of Polish healthcare company Scanmed -sources". Reuters. 17 November 2023.
- ^ "Deal Wrap: Abris exits Scanmed; Monomoy invests in Southern Exteriors". www.spglobal.com. Retrieved 2024-08-13.
- ^ "Abris Capital sets out new approach for delivering sustainable returns". Private Equity Wire. 28 June 2021.
- ^ "Agile & comprehensive ESG management system". Principles for Responsible Investment. 1 November 2020.
- ^ "Abris Capital sets out new approach for delivering sustainable returns". Private Equity Wire. 28 June 2021.
- ^ "ESG Investing, ESG Investing Awards Winners & Finalists 2022". ESG Investing. 18 December 2019.
- ^ "Private Equity Awards 2024: Winners announced". Real Deals. Retrieved 2024-08-13.